目的 探讨哮喘小鼠Th17 细胞和CD4+CD25+ 调节性T 细胞(Treg)在脾组织中表达水平的变化规律及与气道重塑的关系。方法 将SPF 级雌性 Balb/c 小鼠48 只随机分为对照组和哮喘组,利用腹腔注射卵清蛋白(OVA)和氢氧化铝混悬液致敏及雾化吸入OVA 激发制备哮喘气道重塑模型,对照组应用生理盐水替代。两组分别在雾化2 周、4 周及8 周后的24 h 内随机处死8 只小鼠,左肺组织病理切片观察肺气道重塑程度;流式细胞仪测定脾组织中Th17、CD4+CD25+Treg 细胞占CD4+T 细胞的百分比。结果 随着激发时间的延长,哮喘组支气管总管壁面积(Wat/Pbm)及支气管平滑肌面积(Wam/Pbm)逐渐增厚(P<0.01);脾组织细胞悬液中Th17 细胞水平逐渐升高,与气道重塑的程度呈正相关(P<0.01),而CD4+CD25+Treg 细胞水平逐渐降低,与气道重塑程度均呈负相关(P<0.01)。结论 哮喘小鼠气道重塑是动态变化的过程,激发的时间越长,气道重塑越严重,Th17 细胞表达越高,CD4+CD25+Treg 细胞表达越低,两者间免疫失衡可能是哮喘气道重塑发生的重要因素之一。
Abstract
Objective To study the dynamic changes in Th17 cells and CD4+ CD25+ regulatory T cells (Treg) in the spleen and to analyze their relationship with airway remodeling.Methods A total of 48 female specific pathogenfree Balb/c mice were randomly divided into control and asthmatic groups. To establish the asthmatic airway remodeling model, the mice were sensitized to ovalbumin (OVA) through intraperitoneal injection of OVA and aluminum hydroxide suspension and challenged by inhalation of aerosol OVA. The matched control group was treated with normal saline instead. In 24 hours after 2-week, 4-week, and 8-week aerosol inhalation, 8 mice were randomly selected from each group and sacrificed. Then histopathological examination of the left lung was performed to measure the degree of airway remodeling. The percentages of Th17 and CD4+ CD25+ Treg cells in total CD4+ cells from the spleen were determined by flow cytometry.Results In the asthmatic group, the ratios of total bronchial wall area to bronchial basement membrane perimeter (WAt/Pbm) and bronchial smooth muscle area to bronchial basement membrane perimeter (WAm/Pbm) significantly increased as the challenge proceeds (P<0.01). The percentage of Th17 cells derived from the cell suspension of the spleen gradually increased and it was positively correlated with the degree of asthmatic airway remodeling (P<0.01). The percentage of CD4+ CD25+ Treg cells from the suspension gradually decreased and it was negatively correlated with the degree of asthmatic airway remodeling (P<0.01).Conclusions In mice with asthma, as the challenge proceeds, the airway remodeling becomes more severe, the percentage of Th17 cells increases, and the percentage of CD4+ CD25+ Treg cells decreases. The immunological imbalance is possibly one of the important factors inducing airway remodeling.
关键词
哮喘 /
气道重塑 /
TH17 细胞 /
CD4+CD25+ 调节性T 细胞 /
小鼠
Key words
Asthma /
Airway remodeling /
Th17 cell /
CD4+ CD25+ regulatory T cell /
Mice
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] Gershon AS, Guan J, Wang C, et al. Describing and quantifying asthma comorbidity:a population study[J]. PLoS One, 2012, 7(5):e34967.
[2] 陈欣, 林江涛. 我国支气管哮喘防治现状[J]. 内科急危重症 杂志, 2008, 14(5):225-226.
[3] 全国儿科哮喘协作组. 第三次中国城市儿童哮喘流行病学调 查[J]. 中华儿科杂志, 2013, 51(10):729-735.
[4] Halwani R, Al-Muhsen S, Hamid Q. Airway remodeling in asthma[J]. Curr Opin Pharmacol, 2010, 10(3):236-245.
[5] Bergeron C, Al-Ramli W, Hamid Q. Remodeling in asthma[J]. Proc Am Thorac Soc, 2009, 6(3):301-305.
[6] Valentin ED, Crahay C, GarbackiN, et al. New asthma biomarkers:lessons from murine models of acute and chronic asthma[J]. Physiol Lung Cell M olPhysiol, 2009, 296(2):185-197.
[7] Kay AB. Allergy and allergic diseases[J]. N Eng I J Med, 2001, 344(1):30-37.
[8] Van Oosterhout AJ, Motta AC. Th1/Th2 paradigm:not seeing the forest for the trees?[J]. Eur Respir J, 2005, 25(4):591-593.[9] Choi IS. Immune tolerance by induced regulatory T cells in asthma[J]. Allergy Asthma Immunol Res[J]. 2012, 4(3):113-115.
[10] Veldhoen M, Hocking RJ, Atkins CJ, et a1. TGF-β in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells[J]. Immunity, 2006, 24(2):179-189.
[11] 姚斌, 李敏, 庞英. 草分枝杆菌对哮喘小鼠CD4+CD25+ 调节 性T 细胞和Th17 细胞平衡的影响[J]. 中国当代儿科学杂志, 2013, 15(11):1018-1022.
[12] 王绍斌, 沈华浩. 支气管哮喘小鼠气道重塑过程的动态观察[C]. 济南:中华医学会第七次全国呼吸病学术会议, 2006.
[13] Temelkovski J, Hogan SP, Shepherd DP, et al. An improved murine model of asthma:selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen[J]. Thorax, 1998, 53(10):849-856.
[14] 陈跃华, 朱华芳, 范婷婷. 哮喘患儿CD4+CD25+ T 细胞Foxp3 表达的意义[J]. 实用儿科临床杂志, 2007, 22(9):657-658.
[15] Xue K, Zhou Y, Xiong S, et al. Analysis of CD4+ CD25+ regulatory T cells and Foxp3 mRNA in the peripheral blood of patients with asthma[J]. J Huazhong Univ Sci Technolog, 2007, 27(1):31-33.
[16] Zu Y, Li CR, Zheng YJ, et al. The role of CD4+CD25+ regulatory T cells in the pathogenesis of asthma in children[J]. Zhonghua Yi Xue Za Zhi, 2006, 86(1):35-38.
[17] 李敏, 宋丽, 张剑波, 等. 哮喘患儿CD4+ CD25+ Treg 细胞及 IL-10 和TGF-β1 的变化[J]. 中国当代儿科杂志, 2009, 11(10):829-832.
[18] 庞英, 李敏, 张剑波, 等. 糖皮质激素对CD4+ CD25+ 调节 性T 细胞和TLR4 表达的影响[J]. 实用医院临床杂志, 2012, 1(9):60-62.
[19] Jones CE, Chan K. Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine[J]. Am J Respir Cell Mol Biol, 2002, 26(6):748-753.
[20] Oboki K, Ohno T, Saito H, et al. Th17 and allergy[J]. Allergol Int, 2008, 57(2):121-34.
[21] Barczyk A, Pierzchala W, Sozanska E. Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine[J]. Respir Med, 2003, 97(6):726-733.
[22] Kearley J, Barker JE, Robinson DS, et al. Resolution of airway inflammation and hyperreactivity after in vivo transfer ofCD4+CD25+ regulatory T cells is interleukin 10 dependent[J]. ExpMed, 2005, 202(11):1539-1547.
[23] Kearley J, Robinson DS, Lloyd CM. CD4+CD25+ regulatory T cells reverse established allergic airway inflammation and prevent airway remodeling[J]. Allergy Clin Immunol, 2008, 122(3):617-624.
[24] Lauren EM, Ammon-Treiber S, Mothes B, et al. Modified Foxp3 mRNA protects against asthma through an IL-10-dependent mechanism[J]. J Clin Invest, 2013, 123(3):1216-1228.
[25] Donaldson DS, Apostolaki M, Bone HK, et al. The Escherichia coli heat-labile enterotoxin B subunit protects from allergic airway disease development by inducing CD4+ regulatory T cells[J]. Mucosal Immunol, 2013, 6(3):535-546.
[26] 黄花荣, 刘甜甜, 麦贤弟, 等. 哮喘患儿外周血CD4+CD25+ 调节性Ｔ细胞的变化及其与哮喘病情的关系[J]. 新医学, 2009, 40(4):221-223.
[27] Bulek K, Caini Liu, Swaidani S, et al. The inducible kinase IKKi is required for interleukin 17-dependent signaling associated with neutrophilia and pulmonary inflammation[J]. Nat Immunol, 2011, 12(9):844-852.
[28] Molet S, Hamid Q, Davoine F, et al. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines[J]. J Allergy Clin Immunol, 2001, 108(3):430-438.
[29] Molet SM, Hamid QA, Hamilos DL. IL-11 and IL-17 expression in nasal polyps:relation ship to collagen deposition and suppression by intranasal fluticasone propionate[J]. Laryngoscope, 2003, 113(10):1803-1812.
[30] Wang Q, Li H, Yao Y, et al. The overexpression of heparinbinding epidermal growth factor is responsible for Th17-induced airway remodeling in an experimental asthma model[J]. J Immunol, 2010, 185(2):834-841.
[31] Zhao J, Lloyd CM, Noble A. Th17 responses in chronic allergic airway inflammation abrogate regulatory T-cell-mediated tolerance and contribute to airway remodeling[J]. Mucosal Immunol, 2013, 6(2):335-346.
PDF(2895 KB)
